Literature DB >> 16446061

Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.

Fan Lee1, Ming-Hwa Jong, Der-Wei Yang.   

Abstract

For the purpose of removing infected animals by detecting humoral immune responses to non-structural proteins of the foot-and-mouth disease (FMD) virus, antibodies induced by contaminated residual non-structural proteins contained in less pure FMD vaccine can be problematic for serological screening. The aim of the present study was to measure the possible presence of antibodies against these non-structural proteins in repeatedly vaccinated calves and beef cattle. Five imported FMD vaccines were examined using two commercial ELISA kits, UBI FMDV NS EIA and Ceditest FMDV-NS, for serological testing. After five doses of vaccination, the serum of one calf tested positive, and two vaccines induced a significant increase in anti-3ABC antibodies in calves. This finding demonstrated that a positive reaction to non-structural proteins due to impurities in the FMD vaccine was detectable using commercial tests. A low percentage of field sera sampled from beef cattle in Kinmen also tested positive, but the key factor resulting in the positive reactions could not be positively identified based on our data.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446061     DOI: 10.1016/j.vetmic.2005.12.017

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Factors Involved in Removing the Non-Structural Protein of Foot-and-Mouth Disease Virus by Chloroform and Scale-Up Production of High-Purity Vaccine Antigens.

Authors:  Sun Young Park; Sim-In Lee; Jong Sook Jin; Eun-Sol Kim; Jae Young Kim; Ah-Young Kim; Sang Hyun Park; Jung-Won Park; Soonyong Park; Eun Gyo Lee; Jong-Hyeon Park; Young-Joon Ko; Choi-Kyu Park
Journal:  Vaccines (Basel)       Date:  2022-06-24

2.  Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus.

Authors:  Jitendra K Biswal; Antonello Di Nardo; Geraldine Taylor; David J Paton; Satya Parida
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

3.  Laboratory capacity for diagnosis of foot-and-mouth disease in Eastern Africa: implications for the progressive control pathway.

Authors:  Alice Namatovu; Sabenzia Nabalayo Wekesa; Kirsten Tjørnehøj; Moses Tefula Dhikusooka; Vincent B Muwanika; Hans Redlef Siegsmund; Chrisostom Ayebazibwe
Journal:  BMC Vet Res       Date:  2013-01-24       Impact factor: 2.741

4.  Development of a competitive chemiluminescence immunoassay using a monoclonal antibody recognizing 3B of foot-and-mouth disease virus for the rapid detection of antibodies induced by FMDV infection.

Authors:  Wei Liu; Guanglei Zhang; Sicheng Yang; Junhui Li; Zhan Gao; Sudan Ge; Huihui Yang; Junjun Shao; Huiyun Chang
Journal:  Virol J       Date:  2021-09-26       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.